T3 Technion Technology Transfer is the technology transfer unit of the

Technion – Israel Institute of Technology The Technion – Israel Institute of Technology is a public university, public research university located in Haifa, Israel. Established in 1912 by Jews under the dominion of the Ottoman Empire, the Technion is the oldest university in the coun ...

Israel Israel, officially the State of Israel, is a country in West Asia. It Borders of Israel, shares borders with Lebanon to the north, Syria to the north-east, Jordan to the east, Egypt to the south-west, and the Mediterranean Sea to the west. Isr ...

. The unit operates under the auspices of the Technion Research & Development Foundation.

Overview

T3 is staffed by an 11-member team whose focus is to commercialize new ideas in science and technology from Technion in Israel, by finding investors and entrepreneurs to develop commercial applications. This includes licensing

intellectual property Intellectual property (IP) is a category of property that includes intangible creations of the human intellect. There are many types of intellectual property, and some countries recognize more than others. The best-known types are patents, co ...

and the establishment of

start-up A startup or start-up is a company or project undertaken by an entrepreneur to seek, develop, and validate a scalable business model. While entrepreneurship includes all new businesses including self-employment and businesses that do not intend ...

companies. The team has been described as "the private sector's gateway to Technion innovation". The name T3 was taken to represent the three 'T's' in the name Technion Technology Transfer, and to indicate that scientific breakthrough is taken to another dimension (cubed) when developed and applied as solutions in the real world. Since 2005, the unit has been managed by Benjamin Soffer, a lawyer who has served on the board of directors of companies including Genegraft, SLP Ltd, Regentis Biomaterials, EORD, Guide-X and Slender Medical. Soffer was special advisor to Israel's Chief Scientist at the Israeli Ministry of Industry and Trade.

Commercialization strategies

T3's strategy is to escort Technion technologies from the initial point of discovery, through the process of development and licensing, to the formation of ventures with industry. Commercialization strategies are tailored to the requirements of each venture, in order to enhance the

market value Market value or OMV (open market valuation) is the price at which an asset would trade in a competitive auction setting. Market value is often used interchangeably with ''open market value'', ''fair value'' or '' fair market value'', although t ...

and performance of Technion discoveries and increase their success in the global marketplace. This includes: * Analysis of new inventions and concepts developed at the Technion * Licensing technologies developed at the Technion * Incorporation of spin-off companies based on Technion IP * Participation in the board of directors of affiliated companies * Negotiation and approval of the IP and business aspects of agreements with industry

Major developments

Rasagiline

Rasagiline is a drug to treat

Parkinson's disease Parkinson's disease (PD), or simply Parkinson's, is a neurodegenerative disease primarily of the central nervous system, affecting both motor system, motor and non-motor systems. Symptoms typically develop gradually and non-motor issues become ...

discovered by Prof. Moussa B.H. Youdim of Technion and John Finberg. It was developed in collaboration with Teva Pharmaceuticals Ltd, in Israel. Having won U.S.

Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respo ...

approval, the drug is now marketed worldwide as Azilect.

Start-ups formed with T 3 patents

* Mazor Surgical Technologies: Mazor has pioneered the development of miniature, semi robotic bone-mounted positioning systems for a range of orthopedic procedures. * Biosense Inc.: A company that developed a 3-D cardiac mapping and navigation technology. * FineTech: offering sophisticated chemical products and services to the pharmaceutical industry. * Regents Biomaterials Ltd: a medical material development company involved in the cartilage repair market. * Corindus Ltd: a company providing robotic technologies for catheterizing laboratories and radiology/special procedure suites. * Pluristem Therapeutics: developer of human placental adherent stromal cells for commercial use in disease treatment.

Examples of T3 patents

* Novel hypergolic fuel * Source of intense coherent high-frequency radiation * Three-dimensional video scanner * Highly sensitive, real-time structural monitoring * Compact direction finding antenna * Silicon air batteries * GeomCore - outstanding 3D graphics * Adaptive queue management (software and algorithms) * Tandem eletrocyte fuel cell * Learning control scheme for hybrid vehicles

Programs

Entrepreneur in residence program

The unit runs an

Entrepreneur In Residence An entrepreneur in residence, or executive in residence (EIR), is a position commonly held by successful entrepreneurs in venture capital firms, private equity firms, startup accelerators, law firms or business schools. Typically, the EIR has le ...

program, in which global entrepreneurs are recruited and are given the chance to license new Technion technologies. The program normally requires a minimal amount of equity and the presentation of a

business plan A business plan is a formal written document containing the goals of a business, the methods for attaining those goals, and the time-frame for the achievement of the goals. It also describes the nature of the business, background information on ...

. As part of its effort to attract entrepreneurs, the group uses its network of venture capitalists, Incubators, head-hunting firms and

service providers A service provider (SP) is an organization that provides services, such as consulting, legal, real estate, communications, storage, and processing services, to other organizations. Although a service provider can be a sub-unit of the organization t ...

Internal applicable research funds

One challenge in technology transfer is the gap between early research products, and the level of evidence investors need to support further research. The Technion's internal applicable research funds are aimed at bridging this gap by taking promising projects beyond the proof of concept stage.

Awards

The Technion awards researchers, inventions, developments and publications from its scientists that have a profit potential. The goal of the award is to encourage entrepreneurship in research. The researchers are rated based on commercial applicability (such as potential market share), and technological maturity.

The Technion network

The American Technion Society and global Technion societies have created an international network. Many members of Technion Societies are prominent leaders in their respective fields. T3 makes every use of this international source of expertise in the service of its on-going commercialization effort.

Outside Activities

Webinars

The Technion has initiated a webinar program aimed at presenting Technion innovations to an audience of investors, industry leaders, entrepreneurs, corporate executives, in-licensing officers and service providers. The purpose of this program is to increase visibility and to assist in marketing and commercialization efforts. Independently, T3 maintains an active presence in the

social media Social media are interactive technologies that facilitate the Content creation, creation, information exchange, sharing and news aggregator, aggregation of Content (media), content (such as ideas, interests, and other forms of expression) amongs ...

on LinkedIN, Facebook and Twitter.

MBA – global patent course

This program is the result of a combined effort by the Dingman Center for Entrepreneurship at the

University of Maryland The University of Maryland, College Park (University of Maryland, UMD, or simply Maryland) is a public land-grant research university in College Park, Maryland, United States. Founded in 1856, UMD is the flagship institution of the Univ ...

, T3 and Technion's MBA program. Within this initiative, MBA students (an equal amount of Israeli and American students from Maryland University and

Harvard University Harvard University is a Private university, private Ivy League research university in Cambridge, Massachusetts, United States. Founded in 1636 and named for its first benefactor, the History of the Puritans in North America, Puritan clergyma ...

), collaborate on a business plan aimed at commercializing patents and technologies developed by Technion researchers. The course offers hands-on experience in commercialization and starting a company involving a real-life innovation. At the end of the course, students present their business plans to a group of seasoned venture capitalists and serial entrepreneurs.

Internal technology transfer seminars

The group conducts seminars and workshops to Technion faculty and graduate students dealing with different aspects of commercialization, e.g., patenting, entrepreneurship, finance, fund raising, licensing, company formation

Professional conferences

The members of the team present in national and international conferences related to commercialization, licensing, and technology transfer. These include the Israeli, European and US Biome conferences, AUTM conferences, and

Nanotechnology Nanotechnology is the manipulation of matter with at least one dimension sized from 1 to 100 nanometers (nm). At this scale, commonly known as the nanoscale, surface area and quantum mechanical effects become important in describing propertie ...

conferences.

AMIT

The Technion is the first university outside of the U.S. selected by

Alfred E. Mann Alfred E. Mann (1925 – February 25, 2016), also known as Al Mann, was an American physicist, inventor, entrepreneur, and philanthropist. Early life and education Mann was born and raised to a Jewish family in Portland, Oregon. His father was a ...

to be a part of his network of Alfred Mann Institutes (AMIs). The Alfred Mann Institute at the Technion (AMIT) was established with an endowment exceeding US$100 million. Among the patents developed by AMIT is the electronic nose to sniff out cancer, invented by Hossam Haick

References

External links

T3 website
{{DEFAULTSORT:Technion - Israel Institute Of Technology Organizations with year of establishment missing Multidisciplinary research institutes Research institutes in Israel Science and technology in Israel Technion – Israel Institute of Technology